import MCQGroup from '@/components/MCQGroup'
import { Callout } from 'nextra/components'

# Understanding Generalized Anxiety Disorder (GAD)

## Overview of GAD

Generalized Anxiety Disorder (GAD) is a psychiatric condition characterized by excessive, persistent worry and feelings of apprehension. Unlike other anxiety disorders, GAD is not prompted by specific situations, making it a free-floating and chronic condition. It is a common disorder that can impact anyone at any age, and it tends to follow a relapsing-remitting course. The symptoms of GAD are split into psychological and physical categories and can disrupt daily life. Diagnosis is based on clinical criteria from DSM or ICD guidelines, and treatment combines pharmacological and non-pharmacological methods. Most individuals with GAD are managed in primary care settings.

## Symptoms

The symptoms of GAD are extensive and can be broken down into the following categories:

- **Autonomic Symptoms**:
  - Palpitations
  - Sweating
  - Tremor
  - Dry mouth
- **Physical Symptoms**:
  - Shortness of breath
  - Choking
  - Chest pain
  - Nausea
  - Dysphagia (difficulty swallowing)
- **Mental State Symptoms**:
  - Pre-syncope (feeling faint)
  - Derealisation/depersonalisation
  - Fears of losing control or dying
  - Insomnia
  - Irritability
- **Tension Symptoms**:
  - Muscle tension and aches
  - Restlessness
  - Feeling on edge
  - Exaggerated startle response
- **Cognitive Symptoms**:
  - Difficulty concentrating
  - Poor memory

## Diagnosis

To diagnose GAD, clinicians look for the presence of at least four of the above symptoms on most days for a minimum of six months, as per ICD-10 criteria. The GAD-7 questionnaire, a validated screening tool, is also used to measure anxiety severity, with scores indicating mild (â‰¥5), moderate (â‰¥10), or severe (â‰¥15) anxiety. It is important to consider that GAD is a diagnosis of exclusion, requiring a thorough evaluation to rule out other psychiatric or physical health conditions.

## Investigations

While the diagnosis of GAD is primarily clinical, investigations can play a role in excluding other physical health causes. A typical workup may include:

- Routine blood tests (Full Blood Count [FBC], Urea & Electrolytes [U&Es], Thyroid Function Tests [TFTs])
- Cardiac assessments like an Electrocardiogram (ECG) if symptoms suggest a possible heart condition
- Tests for respiratory issues if relevant

<Callout emoji="ðŸ”">
**Note:** Investigations should target ruling out physical illnesses like hyperthyroidism that can mimic anxiety symptoms.
</Callout>

## Management

### Pharmacological Approaches

First-line pharmacological treatment for GAD involves Selective Serotonin Reuptake Inhibitors (SSRIs), with sertraline often being the initial choice. If there is no improvement with sertraline, alternative SSRIs or Serotonin-Noradrenaline Reuptake Inhibitors (SNRIs), such as duloxetine or venlafaxine, may be considered. Neuropathic agents like pregabalin are also options.

<Callout emoji="âš ï¸">
**Warning:** Benzodiazepines are not recommended for long-term use due to the risk of addiction. They are reserved for short-term relief in acute situations.
</Callout>

### Non-Pharmacological Approaches

Non-pharmacological treatment is the first-line approach for GAD, especially in mild cases. Options include:

- Low-intensity interventions: Self-help resources, patient education, and support groups
- High-intensity interventions: Individual Cognitive Behavioural Therapy (CBT) and relaxation therapy for more severe symptoms

Patient education is crucial for long-term management, as understanding the chronic nature of GAD can help patients cope better.

### Referral to Secondary Care

Referral to secondary psychiatric services is rare but may be necessary if:

- There is a risk of self-harm or suicide
- There are significant psychiatric comorbidities, such as substance misuse or depression
- The patient displays self-neglect
- There is no response to initial treatment strategies

In such cases, a psychiatrist may employ combination drug therapies or augment treatment with antipsychotics.

## References

- [Oxford Handbook of Psychiatry, 3rd edition, pages 372-375](#)

---

<MCQGroup questions={[
  {
    question: "A 34-year-old woman presents to the primary care clinic with complaints of persistent worry about various daily life activities, such as job responsibilities, finances, and the health of her family members. She reports feeling 'on edge' most days of the week for the last 8 months. She also experiences difficulty sleeping, muscle tension, and irritability. Her physical examination and routine blood tests are unremarkable. What is the most likely diagnosis?",
    options: [
      "Panic Disorder",
      "Generalized Anxiety Disorder (GAD)",
      "Major Depressive Disorder",
      "Obsessive-Compulsive Disorder (OCD)",
      "Social Anxiety Disorder"
    ],
    correctAnswer: 1,
    correctFeedback: "Correct! The patient's symptoms of persistent worry about a variety of topics, along with additional symptoms of muscle tension, irritability, and sleep disturbances for more than six months, are consistent with the diagnosis of Generalized Anxiety Disorder (GAD).",
    incorrectFeedback: "Consider the duration and nature of the patient's symptoms. The diagnosis of GAD requires persistent worry and additional symptoms such as muscle tension and sleep disturbances for a duration of at least six months."
  },
  {
    question: "A patient with a recent diagnosis of GAD scores 14 on the GAD-7 questionnaire. According to the GAD-7 scoring system, how would you categorize the severity of the patient's anxiety?",
    options: [
      "Mild anxiety",
      "Moderate anxiety",
      "Severe anxiety",
      "The GAD-7 score is not indicative of anxiety severity",
      "The GAD-7 score suggests a different psychiatric disorder"
    ],
    correctAnswer: 1,
    correctFeedback: "Correct! A GAD-7 score of 14 falls within the range of 10 to 14, which is indicative of moderate anxiety according to the GAD-7 scoring system.",
    incorrectFeedback: "Review the GAD-7 scoring system. Scores are categorized as mild (5-9), moderate (10-14), and severe (15 and above)."
  },
  {
    question: "Which of the following investigations is most appropriate to rule out a physical health cause that can mimic symptoms of GAD?",
    options: [
      "Magnetic Resonance Imaging (MRI) of the brain",
      "Thyroid Function Tests (TFTs)",
      "24-hour urine cortisol levels",
      "Upper gastrointestinal endoscopy",
      "Polysomnography (sleep study)"
    ],
    correctAnswer: 1,
    correctFeedback: "Correct! Thyroid Function Tests (TFTs) are important to rule out hyperthyroidism, which can present with anxiety-like symptoms and mimic GAD.",
    incorrectFeedback: "Consider what physical health conditions might present with symptoms similar to GAD and what initial investigations would be appropriate to rule them out."
  },
  {
    question: "A 28-year-old man diagnosed with GAD has not shown significant improvement after an 8-week trial of sertraline. What is the most appropriate next step in managing his pharmacological treatment?",
    options: [
      "Increase the dose of sertraline beyond the maximum recommended dose",
      "Switch to a different Selective Serotonin Reuptake Inhibitor (SSRI) or a Serotonin-Noradrenaline Reuptake Inhibitor (SNRI)",
      "Add a benzodiazepine as a long-term combination therapy with sertraline",
      "Refer the patient for electroconvulsive therapy (ECT)",
      "Prescribe a stimulant medication to address fatigue associated with GAD"
    ],
    correctAnswer: 1,
    correctFeedback: "Correct! If there is no improvement with an initial SSRI such as sertraline, it is appropriate to switch to a different SSRI or consider an SNRI such as duloxetine or venlafaxine for the treatment of GAD.",
    incorrectFeedback: "Consider the recommended treatment options for GAD if a first-line SSRI does not lead to improvement. Also, recall the potential risks associated with long-term use of benzodiazepines."
  }
]} />